High-dose chemotherapy beneficial in Hodgkin's disease

By  

Inpharma, Vol. 1, Iss. 1343, 2002-01 ,pp. : 17-17

Adis International

Access to resources Recommend Favorite

Standard chemo preferable to MDRs for Hodgkin's disease

By  

Inpharma, Vol. 1, Iss. 1521, 2006-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite

Patient beliefs that chemotherapy may be curative and care received at the end of life among patients with metastatic lung and colorectal cancer

By Mack Jennifer W.   Walling Anne   Dy Sydney   Antonio Anna Liza M.   Adams John   Keating Nancy L.   Tisnado Diana  

Cancer, Vol. 121, Iss. 11, 2015-06 ,pp. : 1891-1897

Blackwell Publishing

Access to resources Recommend Favorite

Population Pharmacokinetics of the BEACOPP Polychemotherapy Regimen in Hodgkin's Lymphoma and its Effect on Myelotoxicity

By Wilde Stefan  

Clinical Pharmacokinetics, Vol. 46, Iss. 4, 2007-01 ,pp. : 319-333

Adis International

Access to resources Recommend Favorite

Chemotherapy for advanced gastric cancer: across the years for a standard of care

By Scartozzi Mario   Galizia Eva   Verdecchia Lorena   Berardi Rossana   Antognoli Stefania   Chiorrini Silvia   Cascinu Stefano  

Expert Opinion on Pharmacotherapy, Vol. 8, Iss. 6, 2007-04 ,pp. : 797-808

Informa Healthcare

Access to resources Recommend Favorite